Bortezomib for post-allogeneic hematopoietic stem transplantation relapse and GVHD in multiple myeloma: a single institute experience

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	International journal of hematology 2010-11, Vol.92 (4), p.669-672
Hauptverfasser:	Kuroda, Junya, Kobayashi, Tsutomu, Tsutsumi, Yasuhiko, Yamamoto, Mio, Ohshiro, Muneo, Sasaki, Nana, Shimura, Yuji, Mizutani, Shinsuke, Nagoshi, Hisao, Kiyota, Miki, Nakayama, Ryuko, Uchiyama, Hitoji, Matsumoto, Yosuke, Horiike, Shigeo, Shimazaki, Chihiro, Taniwaki, Masafumi
Format:	Artikel
Sprache:	eng
Schlagworte:	Adolescent Adult Aged Antineoplastic Agents - administration & dosage Antineoplastic Agents - therapeutic use Antineoplastic Combined Chemotherapy Protocols - therapeutic use Biological and medical sciences Boronic Acids - administration & dosage Boronic Acids - therapeutic use Bortezomib Dexamethasone - administration & dosage Dexamethasone - therapeutic use Female Graft vs Host Disease - complications Graft vs Host Disease - drug therapy Hematologic and hematopoietic diseases Hematology Hematopoietic Stem Cell Transplantation Humans Immunodeficiencies. Immunoglobulinopathies Immunoglobulinopathies Immunopathology Letter to the Editor Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis Male Medical sciences Medicine Medicine & Public Health Middle Aged Multiple Myeloma - complications Multiple Myeloma - drug therapy Multiple Myeloma - genetics Multiple Myeloma - therapy Neoplasm Recurrence, Local - drug therapy Oncology Pyrazines - administration & dosage Pyrazines - therapeutic use Retrospective Studies Salvage Therapy Treatment Outcome Young Adult
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:
ISSN:	0925-5710 1865-3774
DOI:	10.1007/s12185-010-0709-3